Reshid Berber1, Yannis Pappas2, Michael Khoo1, Jonathan Miles1, Richard Carrington1, John Skinner1, Alister Hart1. 1. Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, London, Middlesex, HA7 4LP, United Kingdom. E-mail address for R. Berber: reshidb.berber@rnoh.nhs.uk. 2. Institute for Health Research, University of Bedfordshire, Putteridge Bury Campus, Hitchin Road, Luton, Bedfordshire, LU2 8LE, United Kingdom.
Abstract
BACKGROUND: Over one million patients worldwide are estimated to have a metal-on-metal hip arthroplasty. To improve the management of these patients and reduce surgeon uncertainty regarding decision-making, we designed an Internet-enhanced multidisciplinary team (iMDT) working approach. METHODS: From August 2012 to April 2014, the iMDT discussed 215 patients with 266 metal-on-metal hip arthroplasties. Of these, 236 primary arthroplasties (132 hip resurfacing and 104 total hip) were analyzed. The remaining thirty cases involved problematic revised hips and were therefore excluded. The possible recommendations of the iMDT were monitoring, further investigation, or surgery. The concordance between the recommendation and the actual management was used to assess the usefulness of this approach in reducing uncertainty in surgeon-level decision-making. RESULTS: The median Oxford Hip Score was 35 (range, 4 to 48), and median cobalt and chromium levels in whole blood were 3.54 ppb (range, 0.18 to 161.46 ppb) and 3.17 ppb (range, 0.20 to 100.67 ppb), respectively. Magnetic resonance imaging revealed abductor muscle atrophy in ninety-two (39%) of the hips and a pseudotumor in eighty (34%). The iMDT recommended monitoring of 146 (61.9%) of the hips, further investigation of thirty (12.7%), and surgery in sixty (25.4%). The actual outcome was concordant with the recommendation in 211 (91.7%) of the hips. CONCLUSIONS: Our iMDT approach to the metal-on-metal hip burden combines the tacit knowledge of an expert panel, regulatory guidance, and up-to-date evidence to improve decision-making among surgeons. The high level of concordance between the recommendation and the actual outcome, combined with the feasibility of the methods used, suggest that this method effectively reduces uncertainty among surgeons and may lead to improved patient outcomes.
BACKGROUND: Over one million patients worldwide are estimated to have a metal-on-metalhip arthroplasty. To improve the management of these patients and reduce surgeon uncertainty regarding decision-making, we designed an Internet-enhanced multidisciplinary team (iMDT) working approach. METHODS: From August 2012 to April 2014, the iMDT discussed 215 patients with 266 metal-on-metalhip arthroplasties. Of these, 236 primary arthroplasties (132 hip resurfacing and 104 total hip) were analyzed. The remaining thirty cases involved problematic revised hips and were therefore excluded. The possible recommendations of the iMDT were monitoring, further investigation, or surgery. The concordance between the recommendation and the actual management was used to assess the usefulness of this approach in reducing uncertainty in surgeon-level decision-making. RESULTS: The median Oxford Hip Score was 35 (range, 4 to 48), and median cobalt and chromium levels in whole blood were 3.54 ppb (range, 0.18 to 161.46 ppb) and 3.17 ppb (range, 0.20 to 100.67 ppb), respectively. Magnetic resonance imaging revealed abductor muscle atrophy in ninety-two (39%) of the hips and a pseudotumor in eighty (34%). The iMDT recommended monitoring of 146 (61.9%) of the hips, further investigation of thirty (12.7%), and surgery in sixty (25.4%). The actual outcome was concordant with the recommendation in 211 (91.7%) of the hips. CONCLUSIONS: Our iMDT approach to the metal-on-metal hip burden combines the tacit knowledge of an expert panel, regulatory guidance, and up-to-date evidence to improve decision-making among surgeons. The high level of concordance between the recommendation and the actual outcome, combined with the feasibility of the methods used, suggest that this method effectively reduces uncertainty among surgeons and may lead to improved patient outcomes.
Authors: Rami Madanat; Daniel K Hussey; Gabrielle S Donahue; Hollis G Potter; Robert Wallace; Charles Bragdon; Orhun Muratoglu; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2015-08-27 Impact factor: 4.176
Authors: Sang-Hyun Park; Zhen Lu; Robert S Hastings; Patricia A Campbell; Edward Ebramzadeh Journal: Clin Orthop Relat Res Date: 2018-02 Impact factor: 4.176
Authors: Gulraj S Matharu; Fiona Berryman; David J Dunlop; Matthew P Revell; Andrew Judge; David W Murray; Hemant G Pandit Journal: J Arthroplasty Date: 2019-03-13 Impact factor: 4.757
Authors: Merijn E de Swart; Mathilde C M Kouwenhoven; Tessa Hellingman; Babette I Kuiper; Cathelijne Gorter de Vries; Machteld Leembruggen-Vellinga; Niels K Maliepaard; Ernest J Wouda; Bastiaan Moraal; David P Noske; Tjeerd J Postma; Esther Sanchez Aliaga; Bernard M J Uitdehaag; William P Vandertop; Barbara M Zonderhuis; Geert Kazemier; Philip C de Witt Hamer; Maaike Schuur Journal: Neurooncol Pract Date: 2021-07-06